| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1cd6051bf69f25a0652ded4e4edac31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-98 |
| filingDate |
1978-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1981-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38b92094fb8fc61d6441e44c004b7c5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b82e8bdefb2310a5acd6e068664c21 |
| publicationDate |
1981-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1108992-A |
| titleOfInvention |
Pharmaceutical composition containing 1,3-bis(2- carboxychromon-5-yloxy)2-hydroxypropane |
| abstract |
ABSTRACT According to the invention there is provided a pharmaceutical composition in the form of a tablet able to be swallowed and disintegrable in the presence of gastro-intestinal fluids and comprising from 5 to 80% by weight of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane or a pharmaceutically-acceptable salt thereof, in association with from 20 to 95% by weight of a mixture of an alkali-metal or alkaline earth metal carbonate or bicarbonate and citric acid, the tablet having an equilibrated relative humidity of less than 25%. |
| priorityDate |
1977-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |